ZYUS Life Sciences Corporation (TSXV: ZYUS)
Canada
· Delayed Price · Currency is CAD
0.830
-0.020 (-2.35%)
Dec 20, 2024, 10:22 AM EST
ZYUS Life Sciences Company Description
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally.
The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada.
ZYUS Life Sciences Corporation
Country | Canada |
Founded | 2018 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Brent Zettl |
Contact Details
Address: Unit 204 Saskatoon, Ontario S7N 4L8 Canada | |
Phone | 888 651 9987 |
Website | zyus.com |
Stock Details
Ticker Symbol | ZYUS |
Exchange | TSX Venture Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Brent H. Zettl | President, Chief Executive Officer, Secretary and Director |
John M. Hyshka | Chief Financial Officer |
Keith Carpenter CFA | Chief Strategy and Investment Officer |
Michelle Gursky | Vice President of Legal Affairs |
Dr. Lionel Marks de Chabris | Chief Medical Officer |
Tim Miller | Director of Investor Relations and Capital Markets |
Scott William Livingstone | Vice President of Clinical Research |